Serotonin reuptake inhibitors (SRIs) and the risk of fetal congenital heart anomalies (CHA): An exploratory pharmacogenetics study

被引：0
|
作者：
Daud, A. N. A. [1 ,2 ]
Bergman, J. E. H. [3 ]
Kerstjens-Frederikse, W. S. [3 ]
van der Vlies, P. [3 ]
Hak, E. [1 ]
Berger, R. M. F. [4 ]
Groen, H. [5 ]
Wilffert, B. [1 ]
机构：
[1] Univ Groningen, Dept Pharm, Groningen, Netherlands
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[3] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Dept Pediat Cardiol, Groningen, Netherlands
[5] Univ Groningen, Dept Epidemiol, Groningen, Netherlands
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
100
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [41] Selective serotonin reuptake inhibitor (SSRI) use in first trimester pregnancy and risk of congenital anomalies: a EUROmediCAT case-malformed control study in 12 countries
    Boyle, B.
    Loane, M.
    Bakker, M. K.
    Addor, M. C.
    Arriola, L.
    Garne, E.
    Gatt, M.
    Jordan, S.
    Khoshnood, B.
    Klungsoyr, K.
    Nelen, V
    Nevilie, A. J.
    O'Mahoney, M.
    Pierini, A.
    Rissmann, A.
    Tucker, D.
    Wiesel, A.
    Dolk, H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 15 - 15
  • [42] Methodology on Study Using Administrative Data of Selective Serotonin Reuptake Inhibitors during Pregnancy and the Risk of Infants
    Shono, Aiko
    Obara, Taku
    Kuriyama, Shinichi
    Akazawa, Manabu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 389 - 389
  • [43] Selective serotonin reuptake inhibitors and bleeding risk after PCI. A propensity score matching study
    Gonzalez-Manzanares, Rafael
    Ojeda, Soledad
    Hidalgo, Francisco
    Ruiz-Moreno, Marina
    Fernandez-Aviles, Consuelo
    Costa, Francesco
    Flores-Vergara, Guisela
    Suarez De Lezo, Javier
    Carmona-Artime, Luz
    Pan, Manuel
    REC-INTERVENTIONAL CARDIOLOGY, 2022, 4 (02): : 115 - 122
  • [44] Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study
    Alqdwah-Fattouh, Rasha
    Rodriguez-Martin, Sara
    Barreira-Hernandez, Diana
    Izquierdo-Esteban, Laura
    Gil, Miguel
    Gonzalez-Bermejo, Diana
    Fernandez-Anton, Encarnacion
    Rodriguez-Miguel, Antonio
    Garcia-Lledo, Alberto
    Bolumar, Francisco
    de Abajo, Francisco J.
    STROKE, 2022, 53 (05) : 1560 - 1569
  • [45] A cross-sectional study to evaluate the association of selective serotonin reuptake inhibitors with risk of suicidality in adolescents
    Kiranmayi, M.
    Kumar, N. Prasanna
    INDIAN JOURNAL OF PSYCHIATRY, 2025, 67 : S52 - S52
  • [46] Risk of gestational hypertension in women treated with serotonin and norepinephrine reuptake inhibitors: A comparative study in the EFEMERIS database
    Araujo, M.
    Waser, J.
    Hurault-Delarue, C.
    Lacroix, I.
    Damase-Michel, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 67 - 68
  • [47] Selective serotonin reuptake inhibitors and the risk of stroke -: A population-based case-control study
    Bak, S
    Tsiropoulos, I
    Kjærsgaard, JO
    Andersen, M
    Mellerup, E
    Hallas, J
    Rodríguez, LAG
    Christensen, K
    Gaist, D
    STROKE, 2002, 33 (06) : 1465 - 1473
  • [48] Risk of gestational hypertension in women treated with serotonin and norepinephrine reuptake inhibitors: A comparative study in the EFEMERIS database
    Lacroix, Isabelle
    Araujo, Melanie
    Waser, Julie
    Hurault Delarue, Caroline
    Damase Michel, Christine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 239 - 240
  • [49] Selective Serotonin Reuptake Inhibitors (SSRIs) and major congenital heart defects (CHDs): An analysis of FDA Spontaneous Adverse Event Report Databases
    Al-zubiedi, S.
    DRUG SAFETY, 2017, 40 (10) : 991 - 992
  • [50] Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
    Reis, Margareta
    Kallen, Bengt
    BMJ OPEN, 2013, 3 (02):
12345